{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"BioAtla, Inc."},"Symbol":{"label":"Symbol","value":"BCAB"},"Address":{"label":"Address","value":"11085 TORREYANA ROAD, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 558-0708"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs."},"CompanyUrl":{"label":"Company Url","value":"https://www.bioatla.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bin Zhang","title":"Senior Vice President-Clinical Development"},{"name":"Cathy Chang","title":"Vice President-Research & Development"},{"name":"Eric Sievers","title":"Chief Medical Officer"},{"name":"Gerhard Frey","title":"Senior Vice President-Technology Development"},{"name":"Jay M. Short","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}